the scottish health technologies group (shtg) - edward clifton.pdf · • the scottish health...
TRANSCRIPT
• The Scottish Health Technologies Group (SHTG)
– Role and remit
• The Innovative Medical Technology Overview (IMTO) process
– Manufacturer submissions
– HTA-light
– Innovation landscape
CONTENTS
SHTG ROLE AND REMIT
Clinical effectiveness
Cost effectiveness
Context
• Can perform full health technology assessments (HTAs) and
systematic reviews
• Often performs rapid reviews of secondary research
• Presents a balanced and impartial summary of the published
research with Scottish information on costs and contexts
• Provides Advice to NHSScotland to support planning and decision
making in NHS health boards (not mandatory)
SHTG ROLE AND REMIT
Open topic referral mechanism
Short & simple documentation & reasonable ‘hit rate’
Topic referrals from industry...
• Association of British Healthcare Industries (ABHI)
• Life Sciences Advisory Board (LISAB)
• Main SHTG group and Evidence Review Committee
Industry representation
• Template with standard questions and guidance note
• Evidence review and Advice Statement Peer review
• Reps from SHTG, industry, academia, government
• Foster mutual understanding
• Development of processes and methods
• Liaison with manufacturers
• Promoting a culture of innovation, adoption and diffusion
Industry User Group Forum
Statement of Intent for Innovation in Health
Scotland is a world leading centre for innovation in
health through partnership working between
Government, NHSScotland, Industry and the research
community
Strong partnership with industry to ensure NHS
encourages development, marketing and adoption of
medicines (and health technologies) that are better
matched to its needs and which are evidence based
POLICY BACKGROUND
• SHTG is currently piloting their new Innovative Medical Technology
Overview (IMTO) process
• Key aspects of IMTO process
– provide manufacturers of non-medicine technologies the opportunity to
submit their clinical and economic evidence for independent assessment
within NHS Scotland
– provide objective information that will assist decision-making - around
the implementation of innovative technologies - of NHS health
professionals, NHS managers, and procurement colleagues
– SHTG intends that the production of IMTOs will obviate the requirement
for each NHS board within NHSScotland to carry out their own individual
assessments
IMTO PROCESS
• IMTOs are distinguishable from other SHTG evidence products
– evidence may only be emergent or partial
– manufacturers to make a direct case for the adoption and diffusion of their technology within NHSScotland
– developing alongside other national initiatives
• However, IMTOs are also in-keeping with other SHTG evidence products
– Impartial and evidence-based assessment
– SHTG evidence review process has a central role to play in ensuring the appropriate, timely uptake of evidence-based technologies that can yield improvements in health
IMTOS WITHIN SHTG
EVIDENCE HIERARCHY
SHTG
SHTG
IMTOs
IMTO DOCUMENTS
Description & technical characteristics of the technology
Product performance
Safety
Economic considerations
Organisational and patient issues
• Braidlock® - Class I, non-invasive disposable medical device which provides securement for peripheral devices using tubing from 3.5Fr to 36Fr. Braidlock attaches lines, drains and catheters to a patient, and is suitable for use in a variety of clinical settings.
• Granulox® - Class III medical device indicated for the treatment of chronic wounds,
such as venous leg ulcers, arterial leg ulcers, mixed leg ulcers, diabetic foot ulcers,
secondary healing of surgical wounds and pressure sores.
• DySIS® - Class IIa medical device indicated for the colposcopic evaluation of the
cervix on patients that are referred to colposcopy following an abnormal smear result,
and/or a positive human papillomavirus (HPV) deoxyribonucleic acid (DNA) test.
• Ambulight® - Class IIa non-invasive portable light emitting plaster for the treatment
of non-melanoma skin cancer via photodynamic therapy (PDT), and provides a means
of delivering PDT outside a hospital setting.
• Airsonett® - Class I, non-invasive, temperature controlled laminar airflow device
indicated as an add-on therapy for children and adults with severe persistent allergic
asthma whose disease despite pharmacotherapy remains poorly controlled.
IMTO PROCESS – COMPLETED OVERVIEWS
• IMTO documents published – what next?
• IMTOs to contribute to national processes
– Health Innovation Assessment Portal (HIAP)
– Scottish Government’s Innovation Assessment Process (IAP)
– National Procurement
• Recent order for 30,000 units from National Procurement for
one of the technologies having been through the IMTO
process
IMTOS WITHIN THE INNOVATION LANDSCAPE
• Health Innovation Assessment Portal (HIAP)
– Initial point of registration for technologies
– First sift assessment
– Sign-posted as appropriate
• Innovation Assessment Process (IAP)
– Scottish Government proposes creation of a single and
robust process for the assessment of health innovation
proposals
– National sign-off with ‘recommendations’
IMTOS WITHIN THE INNOVATION LANDSCAPE
HEALTH INNOVATION ASSESSMENT PORTAL (HIAP)
• Health Innovation Assessment Portal (HIAP)
• IMTO
– signposting from HIAP
– formal assessment of the technology evidence
– product performance, economics, safety, patient and
organisational issues
– IMTO output feeds into overall IAP decision making
• Innovation Assessment Process (IAP)
IMTOS WITHIN THE INNOVATION LANDSCAPE
• SHTG is an advisory group set up to provide assistance to
NHSScotland boards when considering selected health technologies
• IMTO work stream within SHTG
– Manufacturer submissions
– HTA-light based on ‘lower’ levels of evidence
• IMTOs within the wider policy landscape
– Scottish Government Statement of Intent
– Wider innovation assessment processes
SUMMARY
• SHTG website
– http://www.healthcareimprovementscotland.org/our_work/
technologies_and_medicines/shtg.aspx
• Susan Myles - Lead Health Economist – Scottish Health
Technologies Group
• Ed Clifton – Senior Health Economist
CONTACT US